Who
Richard Barry
President & CEO
Company insider
Files Form 4 as: President & CEO, Filana Therapeutics; Director, Sarepta Therapeutics; Director, MiMedx Group; 10% owner, Telik.
In numbers
- Trades disclosed
- 71
- Buys
- 20
- Sells
- 6
- Bought
- $11.7M
- Sold
- $19.1M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 12 Dec 2012
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $92K100,000 at $0.92 | filing |
| 29 Sep 2026filed 1 Oct 2026 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $186K206,813 at $0.90 | filing |
| 28 Sep 2026filed 30 Sep 2026 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $78K93,091 at $0.84 | filing |
| 28 Sep 2026filed 30 Sep 2026 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $78K93,091 at $0.84 | filing |
| 4 Jun 2026filed 5 Jun 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,875 | filing |
| 4 Jun 2026filed 5 Jun 2026 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code A | —16,875 | filing |
| 20 Nov 2025filed 24 Nov 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $414K150,000 at $2.76 | filing |
| 19 Nov 2025filed 20 Nov 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $202K73,385 at $2.75 | filing |
| 22 Sep 2025filed 23 Sep 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $16K7,172 at $2.28 | filing |
| 19 Sep 2025filed 22 Sep 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $900400 at $2.25 | filing |
| 19 Sep 2025filed 22 Sep 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $107K46,908 at $2.29 | filing |
| 18 Sep 2025filed 22 Sep 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $12K5,400 at $2.13 | filing |
| 18 Sep 2025filed 22 Sep 2025 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Bought | $415K185,233 at $2.24 | filing |
| 16 May 2025filed 19 May 2025 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,350 at $0.00 | filing |
| 16 May 2025filed 19 May 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code M | $403K12,350 at $32.63 | filing |
| 13 May 2025filed 15 May 2025 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,746 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | SRPT Sarepta Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,500 at $0.00 | filing |
| 13 May 2025filed 15 May 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code M | $245K9,746 at $25.18 | filing |
| 13 May 2025filed 15 May 2025 | SRPT Sarepta TherapeuticsBiotechnology | SEC FORM 4 Code M | $144K10,500 at $13.71 | filing |
| 17 Apr 2025filed 21 Apr 2025 | FLNA Filana Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —350,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.